MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0011206
Stanmax Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹20.06 Cr
▲ 55% YoY
Net profit · FY 2024
₹47.33 Lakh
Net margin 2.4%
EBITDA · FY 2024
₹1.4 Cr
EBITDA margin 7%
Authorised capital
₹2.6 Cr
Registered with MCA
Paid-up capital
₹2.33 Cr
Issued & subscribed
Open charges
₹9.85 Cr
Secured borrowings
Company age
30 yrs
Est. 1996
Employees · EPFO
27
Provident fund records
About Stanmax Laboratories Private Limited
Data last updated:
Stanmax Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 02 December 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24235TG1996PTC025837. Its GSTIN is 36AACCS9025N1ZX (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.6 Cr and a paid-up capital of ₹2.33 Cr. It is led by directors including Ghanukota Rupa and Ghanukota Sravan Kumar.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2 – 24 – 86/3/1 Laxmi Narayana Colony Uppal, Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹20.06 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹47.33 Lakh (net margin 2.4%) and EBITDA of ₹1.4 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 25% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Stanmax Labs. As per MCA filings, the company has open charges of ₹9.85 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company.
Stanmax Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011206). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stanmaxlabs.com.
Company Details of Stanmax Laboratories Private Limited
CIN U24235TG1996PTC025837
Registration Number 025837
Incorporation Date 02 December 1996
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0011206
CIN History of Stanmax Laboratories Private Limited
Stanmax Laboratories has one previous CIN (Corporate Identification Number): U24235AP1996PTC025837. The current CIN is U24235TG1996PTC025837, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24235TG1996PTC025837 | Current |
| U24235AP1996PTC025837 | Previous |
Recognitions & Rankings of Stanmax Laboratories
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address2 – 24 – 86/3/1 Laxmi Narayana Colony Uppal, Hyderabad, Telangana, India – 500039
- IndustryPharma, Animal Pharmaceuticals & Healthcare
Comprehensive company report
Stanmax Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Stanmax Laboratories Private Limited
Stanmax Laboratories operates one associated brand: Stanmax Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Veterinary pharmaceuticals and animal health care products for livestock, poultry, and companion animals. | stanmaxlabs.com |
Business Activity of Stanmax Laboratories Private Limited
The main business activity of Stanmax Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stanmax Laboratories Private Limited FY 2025 filings available
Stanmax Laboratories Private Limited reported revenue of ₹20.06 Cr (up 55% YoY) for FY 2024.
Revenue · FY 2024
₹20.06 Cr ▲ 55%
Net profit · FY 2024
₹47.33 Lakh margin 2.4%
EBITDA · FY 2024
₹1.4 Cr margin 7%
Compounded Annual Growth Rate (CAGR) of Stanmax Laboratories Private Limited
Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 26%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 35%
5 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 55% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stanmax Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.4 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹47.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stanmax Laboratories Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stanmax Laboratories are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Stanmax Laboratories Private Limited
Stanmax Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ghanukota Rupa | Director | 04 Apr 2007 | 19 Years 6 Months | Current |
| Ghanukota Sravan Kumar | Director | 28 Mar 2018 | 8 Years 6 Months | Current |
| Shashi Ramu Gunukota | Director | 20 Feb 2025 | 1 Years 8 Months | Current |
| Srija Ghanukota | Director | 20 Feb 2025 | 1 Years 8 Months | Current |
Peer Comparison of Stanmax Laboratories Private Limited
Stanmax Laboratories Private Limited is compared with the companies closest to it by revenue in the Agriculture industry (Animal Feeds, Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Norel NBPL India Private Limited | ₹20.96 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Pune, Maharashtra, India |
| Mack Auraa Healthcare Private Limited | ₹20.88 Cr (FY 2022) | •••• | •••• | 202.0% | •••• | Nashik, Maharashtra, India |
| Bovian Pharma Private Limited | ₹20.82 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Ahmedabad, Gujarat, India |
| Bhagwati Feeds Private Limited | ₹20.65 Cr (FY 2025) | •••• | •••• | -37.0% | •••• | Delhi, India |
| Moraya Feeds Private Limited | ₹20.25 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Baramati, Maharashtra, India |
| Stanmax Laboratories Private Limited this company | ₹20.06 Cr (FY 2024) | •••• | •••• | 55.0% | •••• | Hyderabad, Telangana, India |
| Rescon India Pvt Ltd | ₹20.01 Cr (FY 2023) | •••• | •••• | 19.0% | •••• | Kolkata, West Bengal, India |
| Sarvottam Poultry Feed Supply Centre Private Limited | ₹19.8 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Kunjpura, Haryana, India |
| Vam Lifesciences Private Limited | ₹19.79 Cr (FY 2018) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Poshtiquam Feed Private Limited | ₹19.53 Cr (FY 2024) | •••• | •••• | -34.0% | •••• | Rajpura, Punjab, India |
| P R Feed and Agro Private Limited | ₹19.36 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Punjab, India |
Peers are the five companies nearest above and the five nearest below Stanmax Laboratories by revenue in the Agriculture industry (Animal Feeds, Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Stanmax Laboratories Private Limited
Stanmax Laboratories Private Limited is audited by V.C.MOULI&CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V.C.MOULI&CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Stanmax Laboratories Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stanmax Laboratories Private Limited
Open charges
₹9.85 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2025 | Sidbi | ₹7.5 Cr | Open |
| 25 May 2021 | Axis Bank Limited | ₹1 Cr | Open |
| 27 Nov 2015 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 29 Sep 2014 | Indusind Bank Limited | ₹55 Lakh | Open |
| 30 Jul 2008 | Canara Bank | ₹30 Lakh | Open |
Total charge records: 5 View all charges
Legal Cases of Stanmax Laboratories Private Limited
Stanmax Laboratories Private Limited has 2 court cases on record: 1 filed by Stanmax Laboratories, 1 where it is another party. All cases are disposed. Status as checked on 01 Oct 2026.
Total cases
2
Filed by the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
| High Court for State of Telangana | Writ petition | Company is another party | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Stanmax Laboratories Private Limited
Stanmax Laboratories Private Limited has a workforce of 27 employees as of Apr 06, 2024.
Employee count
27
Active EPFO establishments
1
Employee growth
12.5%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stanmax Laboratories Private Limited
Stanmax Laboratories Private Limited has 8 board changes on record since 2007: 4 appointments and 4 cessations. The latest: Shashi Ramu Gunukota was appointed as Director on 20 Feb 2025.
AGM
Stanmax Laboratories Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Stanmax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Sidbi amounted to Rs. 7.50 Cr with Charge ID 101065316 was registered on 24 Mar 2025.
Appointed
Shashi Ramu Gunukota was appointed as Director.
Appointed
Srija Ghanukota was appointed as Director.
Charges
A charge with Axis Bank Limited of Rs. 1.00 Cr registered on 25 May 2021 with Charge ID 100453191 was modified on 23 Mar 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100453191 was registered on 25 May 2021.
Ceased
Ghanukota Sravan Kumar ceased to be Additional Director.
Ceased
Dasari Sridhar ceased to be Director.
Ceased
Nyapathy Raghunandan ceased to be Director.
Appointed
Ghanukota Sravan Kumar was appointed as Director.
Ceased
Balguri Anuradha ceased to be Director.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Stanmax Laboratories Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stanmax Laboratories Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stanmax Laboratories Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stanmax Laboratories Private Limited
Stanmax Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS9025N1ZX | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stanmax Laboratories Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stanmax Laboratories Private Limited
Stanmax Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 02 December 1996 (30+ years old) and is registered under CIN U24235TG1996PTC025837.
Stanmax Laboratories reported revenue of ₹20.06 Cr for FY 2024 (up 55% YoY).
Stanmax Laboratories has 4 current directors:
- Ghanukota Rupa - Director
- Ghanukota Sravan Kumar - Director
- Shashi Ramu Gunukota - Director
- Srija Ghanukota - Director
Stanmax Laboratories reported a net profit of ₹47.33 Lakh (net margin 2.4%) and EBITDA of ₹1.4 Cr (EBITDA margin 7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stanmax Laboratories is 26% over three years and 25% over five years. In the latest year (FY 2024) revenue rose 55%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stanmax Laboratories is 36AACCS9025N1ZX, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Stanmax Laboratories is U24235TG1996PTC025837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanmax Laboratories has 2 court cases on record: 1 filed by the company. Most are in the high courts.
Stanmax Laboratories was incorporated on 02 December 1996, making it 30+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Stanmax Laboratories by revenue are Norel NBPL India Private Limited, Mack Auraa Healthcare Private Limited, Bovian Pharma Private Limited, Bhagwati Feeds Private Limited, Moraya Feeds Private Limited and 5 more, all in the Agriculture industry (Animal Feeds, Animal Pharma).
Shashi Ramu Gunukota was appointed as Director on 20 Feb 2025. Srija Ghanukota was appointed as Director on 20 Feb 2025. Ghanukota Sravan Kumar ceased to be Additional Director on 28 Sep 2018. Stanmax Laboratories has 8 board changes on record in total.